These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8270139)

  • 1. Susceptibility to type 1 (insulin-dependent) diabetes mellitus is determined by MHC class II molecules. What about DR4?
    Mijovic CH; Jenkins D; Penny MA
    Diabetologia; 1993 Nov; 36(11):1210-1. PubMed ID: 8270139
    [No Abstract]   [Full Text] [Related]  

  • 2. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
    Fujisawa T; Ikegami H; Kawaguchi Y; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Shima K; Ogihara T
    Diabetologia; 1995 Dec; 38(12):1493-5. PubMed ID: 8786033
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility linked to DR4 haplotypes in diabetes of type-1a or associated with polyendocrinopathies (type-1b). The Diabetes Study Group from West France.
    Bignon JD; Semana G; Bardet S; Cheneau ML; Maugendre D; Fauchet R; Muller JY; Genetet B; Allannic A; Sai P
    Tissue Antigens; 1991 Oct; 38(4):183-5. PubMed ID: 1801310
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.
    Rich SS; French LR; Sprafka JM; Clements JP; Goetz FC
    Diabetologia; 1993 Mar; 36(3):234-8. PubMed ID: 8462772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of HLA class II and some autoimmune diseases.
    Lepage V; Lamm LU; Charron D
    Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.
    Awata T; Kuzuya T; Matsuda A; Iwamoto Y; Kanazawa Y
    Diabetologia; 1992 May; 35(5):419-24. PubMed ID: 1521722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
    Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the locus on chromosome 11 implicated in susceptibility to HLA-DR4 dependent type I diabetes mellitus also affect susceptibility to rheumatoid arthritis?
    Pile KD; Wordsworth BP; Bell JI
    Ann Rheum Dis; 1992 Nov; 51(11):1250-1. PubMed ID: 1466604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus type 1 (insulin-dependent). The etiopathogenetic aspects (I)].
    Guerra Vales JM; Damiano Rivero A
    Rev Clin Esp; 1995 Jul; 195(7):479-84. PubMed ID: 7667524
    [No Abstract]   [Full Text] [Related]  

  • 12. No linkage or association of telomeric and centromeric T-cell receptor beta-chain markers with susceptibility to type 1 insulin-dependent diabetes in HLA-DR4 multiplex families.
    McDermott MF; Schmidt-Wolf G; Sinha AA; Koo M; Porter MA; Briant L; Cambon-Thomsen A; Maclaren NK; Fiske D; Bertera S; Trucco M; Amos CI; McDevitt HO; Kastner DL
    Eur J Immunogenet; 1996 Oct; 23(5):361-70. PubMed ID: 8909943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
    Wen L; Chen NY; Tang J; Sherwin R; Wong FS
    J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.
    Nepom GT
    Autoimmunity; 1990; 7(2-3):189-99. PubMed ID: 1716479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II typing using oligonucleotide probes.
    Robinson DM; Holbeck S; Seyfried C; Byers P; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):27-30. PubMed ID: 2499503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multifactorial nature of MHC-linked susceptibility to insulin-dependent diabetes.
    Segurado OG; Arnaiz-Villena A; Wank R; Schendel DJ
    Autoimmunity; 1993; 15(1):85-9. PubMed ID: 8218835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen.
    Aribi M; Moulessehoul S; Benabadji AB; Kendoucitani M
    BMC Genet; 2004 Aug; 5():24. PubMed ID: 15331022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.
    Undlien DE; Friede T; Rammensee HG; Joner G; Dahl-Jørgensen K; Søvik O; Akselsen HE; Knutsen I; Rønningen KS; Thorsby E
    Diabetes; 1997 Jan; 46(1):143-9. PubMed ID: 8971095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.